Literature DB >> 6328505

Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells.

C M Croce, J Erikson, A ar-Rushdi, D Aden, K Nishikura.   

Abstract

We examined somatic cell hybrids between Burkitt lymphoma cells and either human lymphoblastoid cells or mouse plasmacytoma cells for the expression of the translocated c-myc oncogene. The results of this study indicate that the translocated c-myc oncogene is transcribed in plasma cells but is repressed in lymphoblastoid cells. Thus, the factors necessary for translocated c-myc transcription are present in plasma cells and Burkitt lymphoma cells but are absent or inactive in lymphoblastoid cells. Since the distance between the rearranged immunoglobulin loci and the c-myc oncogene can even exceed 30-50 kilobases, we speculate that the translocated c-myc oncogene is under the transcriptional control of enhancer-like elements capable of acting over long distances. The activity of this long-range enhancer may depend on the interaction with transacting factors that are active in plasma cells and in Burkitt lymphoma cells but are not active in lymphoblastoid cells. We also examined the transcription of the first exon of the c-myc oncogene, which becomes separated from the second and third exon because of the chromosomal break involving the first intron. This exon is transcribed at high levels in ST486 Burkitt lymphoma cells with the t(8;14) chromosome translocation. Hybrids between lymphoblastoid and ST486 cells expressed high levels of transcripts of the first exon, whereas hybrids between plasma cells and ST486 cells did not. Thus, transcription of the separated first exon can be enhanced in lymphoblastoid and Burkitt lymphoma cells because of its close proximity to the heavy chain enhancer that is normally located between the joining and the switch region of the C mu gene. Such enhancement, however, does not occur in plasma cells, possibly because these cells are able to suppress completely the c-myc oncogene, unless it has been placed in the proximity of a rearranged immunoglobulin constant region gene.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328505      PMCID: PMC345243          DOI: 10.1073/pnas.81.10.3170

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Chain length determination of small double- and single-stranded DNA molecules by polyacrylamide gel electrophoresis.

Authors:  T Maniatis; A Jeffrey; H van deSande
Journal:  Biochemistry       Date:  1975-08-26       Impact factor: 3.162

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt.

Authors:  C M Croce; W Thierfelder; J Erikson; K Nishikura; J Finan; G M Lenoir; P C Nowell
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

4.  A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene.

Authors:  D Picard; W Schaffner
Journal:  Nature       Date:  1984 Jan 5-11       Impact factor: 49.962

5.  Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma.

Authors:  A ar-Rushdi; K Nishikura; J Erikson; R Watt; G Rovera; C M Croce
Journal:  Science       Date:  1983-10-28       Impact factor: 47.728

6.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

Authors:  R Dalla-Favera; M Bregni; J Erikson; D Patterson; R C Gallo; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

Review 7.  Translocations among antibody genes in human cancer.

Authors:  P Leder; J Battey; G Lenoir; C Moulding; W Murphy; H Potter; T Stewart; R Taub
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

8.  Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas.

Authors:  R Dalla-Favera; S Martinotti; R C Gallo; J Erikson; C M Croce
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

9.  Transcriptional enhancer elements in the mouse immunoglobulin heavy chain locus.

Authors:  M Mercola; X F Wang; J Olsen; K Calame
Journal:  Science       Date:  1983-08-12       Impact factor: 47.728

10.  Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.

Authors:  K Nishikura; A ar-Rushdi; J Erikson; R Watt; G Rovera; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more
  19 in total

1.  Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes.

Authors:  H E Broome; J C Reed; E P Godillot; R G Hoover
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

2.  Strong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoter.

Authors:  E Kakkis; M Mercola; K Calame
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

3.  An active chromatin structure acquired by translocated c-myc genes.

Authors:  E Kakkis; J Prehn; K Calame
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

Review 4.  Genetics of B-cell neoplasia.

Authors:  C M Croce
Journal:  Eur J Epidemiol       Date:  1985-03       Impact factor: 8.082

5.  c-myc can induce expression of G0/G1 transition genes.

Authors:  C W Schweinfest; S Fujiwara; L F Lau; T S Papas
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

6.  Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region.

Authors:  L C Showe; M Ballantine; K Nishikura; J Erikson; H Kaji; C M Croce
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

Review 7.  Use of cultured human tissues and cells in carcinogenesis research.

Authors:  E W Gabrielson; C C Harris
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

Review 8.  Oncogenes and their role in human neoplasia.

Authors:  D N Singh
Journal:  Indian J Pediatr       Date:  1987 Nov-Dec       Impact factor: 1.967

Review 9.  The role of c-myc in the proliferation of normal and neoplastic cells.

Authors:  K Kelly; U Siebenlist
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

10.  Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene.

Authors:  M D Erisman; P G Rothberg; R E Diehl; C C Morse; J M Spandorfer; S M Astrin
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.